Google Ventures and Kleiner Perkins led a $210m Series B round in OpenEvidence.

Google Ventures and Kleiner Perkins, two venture capital firms, led a $210m Series B round in OpenEvidence, a provider of AI-powered medical search and clinical decision support, with participation from Sequoia Capital, Coatue, Conviction, and Thrive. "At a time when U.S. healthcare faces the dual challenges of clinician burnout and a projected physician shortfall of nearly 100k by 2030, the question of AI's role in bridging the gap is paramount. When physicians' lives are hard, patients' lives are harder. OpenEvidence's commitment to building an AI copilot for clinicians is rooted in the belief that AI will be a force for good in the world, ultimately benefiting both healthcare professionals and the patients they serve. Physicians are superheroes, and OpenEvidence is giving these superheroes new superpowers," Daniel Nadler, OpenEvidence founder.